Teresa Gisinger on Sex Hormones and Cardiovascular Risk in Type 2 DM
Teresa Gisinger, Researcher (Doctoral Candidate) at Medical University of Vienna, shared on LinkedIn:
”I’m excited to share our newly published study
We found that in older men with type 2 diabetes, baseline testosterone and changes in estradiol and SHBG after lifestyle intervention are associated with long-term cardiovascular risk, whereas no comparable link was found in postmenopausal women”
Read the full article here.
Article: Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the LookAHEAD Trial
Authors: Teresa Gisinger, Jiahuan Helen He, Chigolum P. Oyeka, Jianqiao Ma, Nityasree Srialluri, Mark Woodward, Erin D. Michos, Rita R. Kalyani, Jeanne M. Clark, Alexandra Kautzky-Willer, Dhananjay Vaidya, Wendy L. Bennett
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters